Broad-spectrum antiviral treatments for enterovirus infections
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
74
NCT05016687
First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 22, 2021
Completion: Mar 22, 2022
Loading map...